Substrate
Topic

23andMe

2 stories related to this topic, newest first.

Genomic and Demographic Data Enable Prediction of GLP-1 Drug Weight Loss Responsesciencenews.org
science27 days ago

Genomic and Demographic Data Enable Prediction of GLP-1 Drug Weight Loss Response

Researchers have identified that genomic and demographic data can predict the magnitude of weight loss from GLP-1 drugs. This approach involves analysis by 23andMe. The findings focus on drug response and side effects in obesity treatment.

ER
1 source
Genetic Variants Linked to Weight Loss Outcomes and Side Effects from GLP-1 Drugssciencenews.org
health27 days ago

Genetic Variants Linked to Weight Loss Outcomes and Side Effects from GLP-1 Drugs

A study published in Nature identifies variations in two genes associated with greater weight loss and increased side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to nearly 28,000 23andMe users, shows modest genetic i…

The Bbc
The Independent
ST
3 sources